Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Study completedNCT00473668
What this trial is testing

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bTetanus+2 more
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Large-scale testing (Phase 3)Study completedNCT00317135
What this trial is testing

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Who this might be right for
DiphtheriaHepatitis BWhole Cell Pertussis+2 more
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT00332566
What this trial is testing

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Who this might be right for
Hepatitis BWhole Cell PertussisTetanus+2 more
GlaxoSmithKline 148
Testing effectiveness (Phase 2)Study completedNCT00317174
What this trial is testing

Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Who this might be right for
Haemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more
GlaxoSmithKline 450
Large-scale testing (Phase 3)UnknownNCT05457946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 1,438
Large-scale testing (Phase 3)Ended earlyNCT00316680
What this trial is testing

Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.

Who this might be right for
Haemophilus Influenzae Type bDiphtheriaTetanus+2 more
GlaxoSmithKline 288
Large-scale testing (Phase 3)Looking for participantsNCT06947499
What this trial is testing

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 1,186
Large-scale testing (Phase 3)Study completedNCT00317122
What this trial is testing

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

Who this might be right for
Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis
GlaxoSmithKline 192
Testing effectiveness (Phase 2)Study completedNCT01106092
What this trial is testing

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Who this might be right for
Haemophilus Influenzae Type bTetanusHepatitis B+3 more
GlaxoSmithKline 312
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617
Large-scale testing (Phase 3)Study completedNCT00290303
What this trial is testing

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

Who this might be right for
Haemophilus Influenzae Type bDiphtheriaWhole Cell Pertussis+2 more
GlaxoSmithKline 996
Large-scale testing (Phase 3)Study completedNCT00317187
What this trial is testing

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Who this might be right for
Hepatitis BDiphtheriaWhole Cell Pertussis+2 more
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745
Post-approval studies (Phase 4)UnknownNCT04056728
What this trial is testing

A Phase IV Study to Assess the Safety of EupentaTM Inj

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more
LG Chem 3,000
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Large-scale testing (Phase 3)Study completedNCT00317161
What this trial is testing

Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.

Who this might be right for
DiphtheriaHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 1,000
Large-scale testing (Phase 3)Study completedNCT00197275
What this trial is testing

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 800